TY - JOUR AU - Miller, K. D. PY - 2016 DA - 2016// TI - Cancer treatment and survivorship statistics, 2016 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21349 DO - 10.3322/caac.21349 ID - Miller2016 ER - TY - JOUR AU - Ferlay, J. PY - 2013 DA - 2013// TI - Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 JO - Eur J Cancer VL - 49 UR - https://doi.org/10.1016/j.ejca.2012.12.027 DO - 10.1016/j.ejca.2012.12.027 ID - Ferlay2013 ER - TY - JOUR AU - Meza, R. PY - 2015 DA - 2015// TI - Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010 JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0121323 DO - 10.1371/journal.pone.0121323 ID - Meza2015 ER - TY - JOUR AU - Morgensztern, D. PY - 2010 DA - 2010// TI - Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey JO - J Thorac Oncol VL - 5 UR - https://doi.org/10.1097/JTO.0b013e3181c5920c DO - 10.1097/JTO.0b013e3181c5920c ID - Morgensztern2010 ER - TY - JOUR AU - Goldstraw, P. PY - 2016 DA - 2016// TI - The IASLC lung Cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung Cancer JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2015.09.009 DO - 10.1016/j.jtho.2015.09.009 ID - Goldstraw2016 ER - TY - JOUR AU - Travis, W. D. PY - 2015 DA - 2015// TI - The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification JO - J Thorac Oncol VL - 10 UR - https://doi.org/10.1097/JTO.0000000000000630 DO - 10.1097/JTO.0000000000000630 ID - Travis2015 ER - TY - JOUR AU - Goldstraw, P. PY - 2011 DA - 2011// TI - Non-small-cell lung cancer JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(10)62101-0 DO - 10.1016/S0140-6736(10)62101-0 ID - Goldstraw2011 ER - TY - JOUR AU - Arriagada, R. PY - 2010 DA - 2010// TI - Long-term results of the international adjuvant lung cancer trial evaluating adjuvant cisplatin-based chemotherapy in resected lung cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.2272 DO - 10.1200/JCO.2009.23.2272 ID - Arriagada2010 ER - TY - JOUR AU - Douillard, J. Y. PY - 2010 DA - 2010// TI - Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the lung adjuvant cisplatin evaluation JO - J Thorac Oncol VL - 5 UR - https://doi.org/10.1097/JTO.0b013e3181c814e7 DO - 10.1097/JTO.0b013e3181c814e7 ID - Douillard2010 ER - TY - JOUR AU - Herbst, R. S. PY - 2016 DA - 2016// TI - Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(15)01281-7 DO - 10.1016/S0140-6736(15)01281-7 ID - Herbst2016 ER - TY - JOUR AU - Miao, L. PY - 2017 DA - 2017// TI - PD-L1 and c-MET expression and survival in patients with small cell lung cancer JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.9765 DO - 10.18632/oncotarget.9765 ID - Miao2017 ER - TY - STD TI - Forde PM, et al. Neoadjuvant PD-1 blockade in Resectable lung Cancer. N Engl J Med. 2018. ID - ref12 ER - TY - JOUR AU - Eisenhauer, E. A. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Seymour, L. PY - 2017 DA - 2017// TI - iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics JO - Lancet Oncol VL - 18 UR - https://doi.org/10.1016/S1470-2045(17)30074-8 DO - 10.1016/S1470-2045(17)30074-8 ID - Seymour2017 ER - TY - JOUR AU - Nishino, M. PY - 2010 DA - 2010// TI - New response evaluation criteria in solid tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy JO - AJR Am J Roentgenol VL - 195 UR - https://doi.org/10.2214/AJR.09.3928 DO - 10.2214/AJR.09.3928 ID - Nishino2010 ER - TY - JOUR AU - Junker, K. PY - 2001 DA - 2001// TI - Grading of tumor regression in non-small cell lung cancer : morphology and prognosis JO - Chest VL - 120 UR - https://doi.org/10.1378/chest.120.5.1584 DO - 10.1378/chest.120.5.1584 ID - Junker2001 ER - TY - STD TI - Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. Hoboken: Wiley; 2013. ID - ref17 ER - TY - JOUR AU - Newcombe, R. G. PY - 1998 DA - 1998// TI - Two-sided confidence intervals for the single proportion: comparison of seven methods JO - Stat Med VL - 17 UR - https://doi.org/3.0.CO;2-E DO - 3.0.CO;2-E ID - Newcombe1998 ER - TY - JOUR AU - Goeckenjan, G. PY - 2010 DA - 2010// TI - Prevention, diagnosis, therapy, and follow-up of lung cancer JO - Pneumologie VL - 64 Suppl 2 UR - https://doi.org/10.1055/s-0029-1243837 DO - 10.1055/s-0029-1243837 ID - Goeckenjan2010 ER - TY - JOUR AU - Goldstraw, P. PY - 2007 DA - 2007// TI - The IASLC lung Cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours JO - J Thorac Oncol VL - 2 UR - https://doi.org/10.1097/JTO.0b013e31812f3c1a DO - 10.1097/JTO.0b013e31812f3c1a ID - Goldstraw2007 ER - TY - JOUR AU - Zhong, W. PY - 2008 DA - 2008// TI - Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer JO - Eur J Cardiothorac Surg VL - 34 UR - https://doi.org/10.1016/j.ejcts.2008.03.060 DO - 10.1016/j.ejcts.2008.03.060 ID - Zhong2008 ER - TY - JOUR AU - Yamauchi, Y. PY - 2015 DA - 2015// TI - The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: experiences at a single institution JO - Lung Cancer VL - 90 UR - https://doi.org/10.1016/j.lungcan.2015.09.010 DO - 10.1016/j.lungcan.2015.09.010 ID - Yamauchi2015 ER - TY - JOUR AU - Hanna, G. G. PY - 2014 DA - 2014// TI - Preoperative chemotherapy for non-small-cell lung cancer JO - Lancet VL - 384 UR - https://doi.org/10.1016/S0140-6736(14)61208-3 DO - 10.1016/S0140-6736(14)61208-3 ID - Hanna2014 ER - TY - JOUR AU - McElnay, P. AU - Lim, E. PY - 2014 DA - 2014// TI - Adjuvant or neoadjuvant chemotherapy for NSCLC JO - J Thorac Dis VL - 6 ID - McElnay2014 ER - TY - JOUR AU - Reck, M. PY - 2016 DA - 2016// TI - Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung Cancer JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1606774 DO - 10.1056/NEJMoa1606774 ID - Reck2016 ER - TY - JOUR AU - Borghaei, H. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung Cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1507643 DO - 10.1056/NEJMoa1507643 ID - Borghaei2015 ER - TY - JOUR AU - Lima Lopes, G. PY - 2016 DA - 2016// TI - P2.43: Pembrolizumab vs platinum-based chemotherapy for PD-L1+ NSCLC: phase 3, randomized, open-label KEYNOTE-042 (NCT02220894): track: immunotherapy JO - J Thorac Oncol VL - 11 UR - https://doi.org/10.1016/j.jtho.2016.08.114 DO - 10.1016/j.jtho.2016.08.114 ID - Lima Lopes2016 ER - TY - JOUR AU - Ilie, M. PY - 2016 DA - 2016// TI - Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv489 DO - 10.1093/annonc/mdv489 ID - Ilie2016 ER - TY - JOUR AU - Janku, F. PY - 2011 DA - 2011// TI - Novel therapeutic targets in non-small cell lung cancer JO - J Thorac Oncol VL - 6 UR - https://doi.org/10.1097/JTO.0b013e31822944b3 DO - 10.1097/JTO.0b013e31822944b3 ID - Janku2011 ER - TY - JOUR AU - Azuma, K. PY - 2014 DA - 2014// TI - Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu242 DO - 10.1093/annonc/mdu242 ID - Azuma2014 ER - TY - JOUR AU - Santelmo, C. PY - 2013 DA - 2013// TI - Coexistence of EGFR mutation and ALK translocation in NSCLC: literature review and case report of response to gefitinib JO - Lung Cancer VL - 81 UR - https://doi.org/10.1016/j.lungcan.2013.04.009 DO - 10.1016/j.lungcan.2013.04.009 ID - Santelmo2013 ER - TY - JOUR AU - Yoneshima, Y. PY - 2018 DA - 2018// TI - PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements JO - Lung Cancer VL - 118 UR - https://doi.org/10.1016/j.lungcan.2018.01.024 DO - 10.1016/j.lungcan.2018.01.024 ID - Yoneshima2018 ER - TY - JOUR AU - Liu, J. PY - 2016 DA - 2016// TI - Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-16-0577 DO - 10.1158/2159-8290.CD-16-0577 ID - Liu2016 ER - TY - JOUR AU - Pircher, A. PY - 2014 DA - 2014// TI - Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients JO - Lung Cancer VL - 85 UR - https://doi.org/10.1016/j.lungcan.2014.04.001 DO - 10.1016/j.lungcan.2014.04.001 ID - Pircher2014 ER - TY - JOUR AU - Facciabene, A. AU - Motz, G. T. AU - Coukos, G. PY - 2012 DA - 2012// TI - T-regulatory cells: key players in tumor immune escape and angiogenesis JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3687 DO - 10.1158/0008-5472.CAN-11-3687 ID - Facciabene2012 ER - TY - JOUR AU - Robinson, L. A. PY - 2007 DA - 2007// TI - Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition) JO - Chest VL - 132 UR - https://doi.org/10.1378/chest.07-1379 DO - 10.1378/chest.07-1379 ID - Robinson2007 ER - TY - JOUR AU - Goeckenjan, G. PY - 2011 DA - 2011// TI - Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German respiratory society and the German Cancer society JO - Pneumologie VL - 65 UR - https://doi.org/10.1055/s-0030-1255961 DO - 10.1055/s-0030-1255961 ID - Goeckenjan2011 ER -